Research output per year
Research output per year
- 11 results
Search results
-
2023
Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders
Olsson, A., Westesson, L. M., Baghaei, F., Holmström, M., Olsson, E., Magnusson, M., Ranta, S., Astermark, J., Andersson, N. G., Thanner, J., Szamosi, J., Daoura, L. & Sennfält, K., 2023, In: Haemophilia. 29, 1, p. 377-381Research output: Contribution to journal › Letter › peer-review
-
2022
Autologous cell therapy - A new concept to eradicate inhibitors in haemophilia
Xie, H., Ljung, R., Astermark, J. & Hylander, T., 2022 Nov, In: Haemophilia. 28, 6, p. e259-e261Research output: Contribution to journal › Letter › peer-review
Open Access -
2021
Identification of F8 rearrangements in carrier and non-carrier mothers of haemophilia A patients
Manderstedt, E., Lind-Halldén, C., Ljung, R., Astermark, J. & Halldén, C., 2021, In: Haemophilia. 27, 5, p. 1-5Research output: Contribution to journal › Letter › peer-review
-
Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders
Holmström, M., Olsson, E., Astermark, J., Axelsson, M., Olsson, A., Myrin Westesson, L., Falk, A., Szamosi, J. & Sennfält, K., 2021, In: Haemophilia. 27, 4Research output: Contribution to journal › Letter › peer-review
-
2014
A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
Berntorp, E., Shapiro, A. D., Waters, J. & Astermark, J., 2014, In: Haemophilia. 20, 5, p. e362-e364Research output: Contribution to journal › Letter
-
Clinically relevant non-neutralizing anti-FVIII antibodies in a hemophiliac
Klintman, J., Hillarp, A., Berntorp, E. & Astermark, J., 2014, In: International Monitor on Hemophilia. 22, p. 19–21Research output: Contribution to journal › Letter › peer-review
-
2012
Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
Hermans, C., Astermark, J. & De Moerloos, P., 2012, In: Journal of Thrombosis and Haemostasis. 10, 10, p. 2194-2196Research output: Contribution to journal › Letter
-
The international factor IX treatment network survey.
Berntorp, E., Shapiro, A. D., Waters, J. & Astermark, J., 2012, In: Haemophilia. 18, 3, p. e60-e62Research output: Contribution to journal › Letter
-
2008
Variability of clinical manifestations of factor VII-deficiency in subjects homozygous or heterozygous for the F7 gene mutation A294V
Herrmann, F. H., Wulff, K., Strey, R., Siegemund, A., Astermark, J. & Schulman, S., 2008, In: Haematologica. 93, 8, p. 1273-1275Research output: Contribution to journal › Letter
-
2005
Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.
Berntorp, E., Astermark, J., Donfield, S. M., Nelson, G. W., Oldenburg, J., Shapiro, A. D., Dimichele, D. M., Ewenstein, B. M., Gomperts, E. D. & Winkler, C. A., 2005, In: Haemophilia. 11, 4, p. 427-429Research output: Contribution to journal › Letter › peer-review
-
2003
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp, E., Astermark, J., Björkman, S., Blanchette, V. S., Fischer, K., Giangrande, P. L. F., Gringeri, A., Ljung, R., Manco-Johnson, M. J., Morfini, M., Kilcoyne, R. F., Petrini, P., Rodriguez-Merchan, E. C., Schramm, W., Shapiro, A., M Van Den Berg, H. & Hart, C., 2003, In: Haemophilia. 9, Suppl 1, p. 41278Research output: Contribution to journal › Letter › peer-review
File434 Downloads (Pure)